Ertuğrul, M. B. Et Al. 2021. Evaluation of the efficacy and safety of topical epidermal growth factor Regen-D® in diabetic foot wounds: a randomised, parallel group phase III study.. THE DIABETIC FOOT JOURNAL , vol.24, no.2 , 52-57.

Ertuğrul, M. B., Yapar, N., Taşbakan, M., Polat Düzgün, A., Özker, E., Aktaş, Ş., ... Kaya, B.(2021). Evaluation of the efficacy and safety of topical epidermal growth factor Regen-D® in diabetic foot wounds: a randomised, parallel group phase III study.. THE DIABETIC FOOT JOURNAL , vol.24, no.2, 52-57.

Ertuğrul, Mustafa Et Al. "Evaluation of the efficacy and safety of topical epidermal growth factor Regen-D® in diabetic foot wounds: a randomised, parallel group phase III study.," THE DIABETIC FOOT JOURNAL , vol.24, no.2, 52-57, 2021

Ertuğrul, Mustafa B. Et Al. "Evaluation of the efficacy and safety of topical epidermal growth factor Regen-D® in diabetic foot wounds: a randomised, parallel group phase III study.." THE DIABETIC FOOT JOURNAL , vol.24, no.2, pp.52-57, 2021

Ertuğrul, M. B. Et Al. (2021) . "Evaluation of the efficacy and safety of topical epidermal growth factor Regen-D® in diabetic foot wounds: a randomised, parallel group phase III study.." THE DIABETIC FOOT JOURNAL , vol.24, no.2, pp.52-57.

@article{article, author={Mustafa Bülent Ertuğrul Et Al. }, title={Evaluation of the efficacy and safety of topical epidermal growth factor Regen-D® in diabetic foot wounds: a randomised, parallel group phase III study.}, journal={THE DIABETIC FOOT JOURNAL}, year=2021, pages={52-57} }